Drug Company Trying to Rip Off $millions From N.Z Economy
This is the usual scenario..
Drug company kindly sponsors study..
Drug company pre-releases false information..
Drug company saves the day with new pills..
Study Data proves nothing....
Drug company uses $billions profit to bury facts...
Drug company kindly sponsors study..
Now Read the Facts.
News release from 30/3/98
Taking "bad" cholesterol even lower.
A new multinational study is being launched to investigate whether lowering LDL-cholesterol to levels below current clinical practice can further reduce the chances of death or heart attack in patients with coronary heart disease.
The five year trial involving 8600 patients in 250 sites is co-sponsored by Parke-Davis and Pfizer. Patients will be treated with Lipitor (atorvastatin calcium) tablets. Since the effect of Lipitor on cardiovascular morbidity and mortality is unknown, this is one of the studies under way to determine its effect.
Business Wire, 30 March1998 [www.newspage.com]
And just over one year later:July 1999
Trial called off early due to supposedly successful early results(VERY SCIENTIFIC]
The Following letter has been sent to every Doctor in New Zealand in an attempt to rip off the New Zealand taxpayers of $millions.
Trundling out Discredited Data from the Framington Study in an attempt to further perpetuate the myth about High Cholesterol, and before their latest Study has hardly started Drug Giants Parke Davis have launched an all out assault on the New Zealand Market. If your Doctor pulls out a red plastic folder and tries to talk you into taking STATIN TYPE DRUGS to lower your Cholesterol then you will know he has been fooled.
Before you take any of these evil drugs CLICK HERE
to read about the Framington Fraud
To read about the Cholesterol Myth click here.
There is absolutely no evidence to support any claim that you will live longer by taking Statin Type Drugs.There is plenty of evidence to show you may very well die of cancer. click here to see the drug companies findings
You would gain more by drinking 8 glasses of water per day and its FREE.
EXAMPLE OF DRUG COMPANY PROFIT.
April 21, 1999
BRISTOL-MYERS SQUIBB REPORTS RECORD FIRST QUARTER SALES & EARNINGS
Sales Increase 9% to $4.9 Billion, an Increase of 10% Excluding Divested Businesses - Worldwide Pharmaceutical Sales Up 15% - Domestic Pharmaceutical Sales Up 21%
Read the Drug Company letter:THE MISSION
A message from Parke Davis
In the interest of improving the cardiovascular health of New Zealanders
Dear Dr XXXXXXXX,
Coronary Heart Disease affects many of your patient's lives!
New Zealand statistics for Coronary Heart Disease (CHD) make shocking reading. CHD kills one out of 4 men, and one out of 8 women.
1.Data from the Framingham Study indicates that from the age of 40, men have a 1 in 2 risk of CHD in their lifetime.
2. Recently, data on survivors of myocardial infarction, discharged from Auckland hospitals, was published in the New Zealand Medical Journal. At a median of 5.5 years follow up, only 32% of patients were receiving lipid lowering therapy! Regardless of whether they were taking cholesterol lowering medication or not, 69% had a total cholesterol greater than 5.2 mmol/L
3 Join the Mission - Cholesterol Must Come Down.
It is estimated that over 100,000 New Zealanders are eligible for statin lipid lowering therapy, yet aren't receiving it.
4. That's an average of 30-40 patients per GP practice. Most of these patients already have CHD, and New Zealand experts recommend their cholesterol should be lowered to 4 -- 4.5 mmol/L.
5 You're in a unique position to make a difference to New Zealand's ranking on the international CHD death scale.
'The Mission' is to get cholesterol levels down in patients with CHD and hypercholesterolaemia. Over the next few months, Parke Davis will provide you with additional tools and resources. Research tells us that the great majority of you believe our efforts are valuable but it can only happen with your help. You may wish to target the most likely patients for cholesterol lowering; people who had their angina diagnosed years ago or who may have experienced a heart attack before you had access to effective cholesterol lowering medicines.You might like to use the enclosed stickers on your patient files to identify priorities for a comprehensive lipid test. We've designed the enclosed desk cholesterol guide to help you talk the issue through with your patients. It quickly and clearly presents the importance of cholesterol lowering for your at risk patients. More resource material is available on request - please use the free, fax back form or talk to your local 'representative.
And look out for our extensive advertising campaign for doctors and specialists, starting this week in the medical media.
6 As the leaders in cardiovascular medicine Parke Davis are committed to ensuring that significantly more CHD sufferers receive the cholesterol lowering therapy they need and deserve.
We're excited about the challenge and we look forward to your support.
SENIOR PRODUCT MANAGER USE THE LINKS PROVIDED AT THE TOP OF THIS PAGE TO FIND OUT FOR YOURSELF THE LIES DRUG COMPANIES ARE TELLING THE WORLD.
The author has no interest either financial or otherwise in any products that may be available by following the links off this site other than trying to save 26476221 lives.